Viewing Study NCT03630120

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-02-27 @ 11:20 AM
Study NCT ID: NCT03630120
Status: TERMINATED
Last Update Posted: 2021-07-14
First Post: 2018-08-10
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Thyroid Cancer View
None Thyroid Cancer, Medullary View
None Differentiated Thyroid Cancer View
None Papillary Thyroid Cancer View
None Follicular Thyroid Cancer View
None Poorly Differentiated Thyroid Gland Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Thyroid disease View
None Tyrosine kinase inhibitor View
None TKI View
None Medullary thyroid cancer View
None DTC View
None Advanced thyroid cancer View
None Progressive thyroid cancer View
None MTC View